Multi-Drug Resistance in Emerging and Re-Emerging Diseases

1. Auflage 2001
ISBN: 978-0-8493-0983-0
Verlag: Taylor & Francis

Buch, Englisch, 282 Seiten, Format (B × H): 127 mm x 191 mm, Gewicht: 644 g

The recent appearance of multi-drug resistant phenotypes has complicated the efforts to completely eradicate diseases such as tuberculosis and malaria, thus underscoring the need for new and innovative scientific approach to the problem. Multi-Drug Resistance in Emerging and Re-Emerging Diseases highlights the state-of-the-art in microbial/parasite control and containment, and discusses ways and means of avoiding development of drug resistance. It explores strategies to combat the nightmare of microbial aggression and resistance and to overcome multiple drug resistance when it emerges in microbial organisms or in cancer cells exposed to chemotherapy. Written by a panel of experts, the book gives you the benefits of both field and clinical experience as well as an in-depth know-how of the pathology of these drug resistant diseases. Topics include malaria, tuberculosis, cholera, leprosy, diarrhoeal diseases, nosocomial diseases, plague, and drug resistance and cancer. Multi-Drug Resistance in Emerging and Re-Emerging Diseases provides a foundation for new initiatives and more collaborative efforts in the fight against resistance to antibiotics by micro-organisms.

Zielgruppe

Physicians, Medical Researchers, PharmacologistsMarketing Class Code: 1I, 1L05, 1L09WEB CODES: LIF09, MED01C, MED01EShelving Guide: Medicine Contact Editor: Melissa Blockmon

Autoren/Hrsg.

Mahajan, R.C.

Therwath, Amu

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Epidemiologie, Medizinische Statistik
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Infektionskrankheiten
• Naturwissenschaften Biowissenschaften Mikrobiologie

Inhaltsverzeichnis

Drug Resistance in Cancer, J.P. MarieMDR: Its Impact on Treatment of AIDS and TB, N.K. Ganguly and V.M. KatochCurrent Pandemics of Cholera and Strategy of Cholera Vaccines, J.-M. FournierEmerging Clones of Vibrio Cholerac and Multi-Drug Resistance, P. Garg, A. Basu, T. Ramaurthy, C. Sharma, S. Maiti, A. Ghosh, S.K. Bhattacharya, Y. Takeda, and G.B. NairEmergence of Plasmid-Mediated Antibiotic Resistance in Yersinia Pestis, A. Guiyoule, G. Gerbaud, C. Buchrieser, M. Galimand, L. Rahalison, S. Chanteau, P. Courvalin, and E. CarnielProgress and Prospect of Chemotherapy Research in Leprosy, M.D.B. JiDiagnosis of Leprosy in India, U. SenguptaNew Drug Targets in Tuberculosis, J.L. Herrmann and P.H. LagrangeNewer DNA Fingerprinting Techniques for Tuberculosis-Relevance in Control, V.M. Katoch, D. Singh, D.S. Chauhan, V.D. Sharma, H.B. Singh, R. Das, and K. SrivastavaThe Molecular Basis of Isoniazid Resistance in Mycobacterium Tuberculosis, B. HeynMycobacterium tuberculosis: Studies on Gene Regulation, Pathogenesis and Development of Recombinant BCG Vaccines, A.K. Tyagi and S. Jain Progress for Deciphering Mycobacterium tuberculosis Pathogenicity, J.-M. Reyrat and B. GicquelMulti-Drug Resistant Tuberculosis, N. SelvakumarNew Targets for Malaria Drug Development, A.V. Pandey and V.S. ChauhanMolecular Aspects of Chloroquine and Antifols Resistance in Plasmodium falciparum, J. Le Bras and R. DurandImport of Host Enzymes into the Malarial Parasite can be a New Drug Target, Z.Q. Bonday and G. PadmanabanNew Drugs Against Malaria with Special Reference to Effectors of the Plasmodial Phospholipid Metabolism, H.J. Vial, V. Vidal-Sailhant, M.L. Ancelin, S. Herbute, D. Martin, F. Baunaure, and M. CalasStatus of Drug Resistance in Malaria in India, V.P. SharmaAntimalarial as Drug Resistance in Africa: Epidemiological Background of a Disaster, J.F. TrapeCan India Control the Spread of HIV/AIDS? T.J. JohnA Strategy to Control the Emergence of Antimicrobial Resistance, H. RichetNew Trends in Opportunistic Infections in HIV Patients, D. SereniOpportunistic Fungal and Mycobacterial Infections in Cancer Patients, R. KelkarPathogenicity of Enterovirulent Escherichia coli, A.L. ServinMulti-Drug Resistant Salmonella typhi: The Problem and Possible Solutions, M.V. JesudasonP53, BCL-2 and Drug Resistance in Cancer, A. TherwathMultiple Drug Resistance in Cancer, A.H. BhiseyDiagnostic Tools in Clinical for MDR, S. Chevillard, J. Ronert, and J.P. MarieMulti-Drug Resistance in Acute Leukaemias, M. Bhargava, S. Gurbuxani, J.-P. Marie, and A. TherwathMultiple Drug Resistance in Solid Tumors, P. VielhMulti-Drug Resistance: Therapeutic Regimen Against Bacteria and Virus Cells, A.V.R. Rao